Antiviral treatment in patients with cytomegalovirus positive ulcerative colitis
Antiviral treatment in patients with cytomegalovirus positive ulcerative colitis作者机构:Department of Gastroenterology Gulhane School of Medicine GATA Gastroenteroloji BD Etlik 06010 AnkaraTurkey
出 版 物:《World Journal of Gastrointestinal Pathophysiology》 (世界胃肠病理生理学杂志(英文版)(电子版))
年 卷 期:2014年第5卷第4期
页 面:589-590页
主 题:Cytomegalovirus Ulcerative colitis Antiviral treatment Steroid resistant Colonoscopy
摘 要:Cytomegalovirus(CMV) is a common virus in patients with ulcerative colitis receiving immunosuppressive drugs. Many studies suggested that CMV infection is an exacerbating factor in patients with ulcerative colitis. The role of CMV in exacerbations of ulcerative colitis has been discussed. One of studies starting this discussion is an article entitled CMV positive ulcerative colitis: A single center experience and literature review by Kopylov et al. However, we think that there are some points that should be emphasized about the study. Especially, the small number of patients in the study has led to meaningless results. Large controlled prospective trials are needed to clarify the benefit of antiviral therapy for active ulcerative colitis patients.